Serum Albumin Level Can Predict Immunotherapy Response of Neuromyelitis Optica Spectrum Disorders in the Acute Phase

References

• Kim HH, Jeong IH, Hyun JS, Kong BS, Kim HJ, Park SJ. Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance. PLoS One. 2017;12(7):1.
   Web of Science ®Google Scholar
• Marignier R, Cobo Calvo A, Vukusic S. Neuromyelitis optica and neuromyelitis optica spectrum disorders. Curr Opin Neurol. 2017;30(3):208–215. doi:10.1097/WCO.0000000000000455
   PubMed Web of Science ®Google Scholar
• Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106–2112. doi:10.1016/S0140-6736(04)17551-X
   PubMed Web of Science ®Google Scholar
• Bruscolini A, Sacchetti M, La Cava M, et al. Diagnosis and management of neuromyelitis optica spectrum disorders - an update. Autoimmunity Rev. 2018;17(3):195–200. doi:10.1016/j.autrev.2018.01.001
   PubMed Web of Science ®Google Scholar
• Bonnan M, Valentino R, Debeugny S, et al. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. J Neurol Neurosurg. 2018;89(4):346–351. doi:10.1136/jnnp-2017-316286
   PubMed Web of Science ®Google Scholar
• Banerjee A, Ng J, Coleman J, Ospina JP, Mealy M, Levy M. Outcomes from acute attacks of neuromyelitis optica spectrum disorder correlate with severity of attack, age and delay to treatment. Mult Scler Relat Disord. 2019;28:60–63. doi:10.1016/j.msard.2018.12.010
   PubMed Web of Science ®Google Scholar
• Jiao Y, Cui L, Zhang W, et al. Plasma exchange for neuromyelitis optica spectrum disorders in Chinese patients and factors predictive of short-term outcome. Clin Ther. 2018;40(4):603–612. doi:10.1016/j.clinthera.2018.03.007
   PubMed Web of Science ®Google Scholar
• Sleep D. Albumin and its application in drug delivery. Expert Opin Drug Deliv. 2015;12(5):793–812. doi:10.1517/17425247.2015.993313
   PubMed Web of Science ®Google Scholar
• LeVine SM. Albumin and multiple sclerosis. BMC Neurol. 2016;16(1):47. doi:10.1186/s12883-016-0564-9
   PubMedGoogle Scholar
• Jang Y, Lee S-T, Kim T-J, et al. High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis. Sci Rep. 2018;8(1):1012. doi:10.1038/s41598-018-19490-z
   PubMedGoogle Scholar
• Fokkink W-JR, Walgaard C, Kuitwaard K, Tio-Gillen AP, van Doorn PA, Jacobs BC. Association of albumin levels with outcome in intravenous immunoglobulin-treated guillain-barré syndrome. JAMA Neurol. 2017;74(2):189–196. doi:10.1001/jamaneurol.2016.4480
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189. doi:10.1212/WNL.0000000000001729
   PubMed Web of Science ®Google Scholar
• Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002;58(1):143–146. doi:10.1212/WNL.58.1.143
   PubMed Web of Science ®Google Scholar
• Matos MJ. Learning from nature: the role of albumin in drug delivery. Future Med Chem. 2018;10(9):983–985. doi:10.4155/fmc-2018-0053
   PubMed Web of Science ®Google Scholar
• Pyzik M, Rath T, Lencer WI, Baker K, Blumberg RS. FcRn: the architect behind the immune and nonimmune functions of IgG and albumin. J Immunol. 2015;194(10):4595–4603. doi:10.4049/jimmunol.1403014
   PubMed Web of Science ®Google Scholar
• Abboud R, Akil M, Charcosset C, Greige-Gerges H. Interaction of glucocorticoids and progesterone derivatives with human serum albumin. Chem Phys Lipids. 2017;207(Pt B):271–278. doi:10.1016/j.chemphyslip.2017.04.007
   PubMedGoogle Scholar
• Hammond GL. Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J Endocrinol. 2016;230(1):R13–R25. doi:10.1530/JOE-16-0070
   PubMed Web of Science ®Google Scholar
• Kontermann RE. Half-life extended biotherapeutics. Expert Opin Biol Ther. 2016;16(7):903–915. doi:10.1517/14712598.2016.1165661
   PubMed Web of Science ®Google Scholar
• Lin Y, Li C, Li J, et al. NEP(1-40)-modified human serum albumin nanoparticles enhance the therapeutic effect of methylprednisolone against spinal cord injury. J Nanobiotechnol. 2019;17(1):12. doi:10.1186/s12951-019-0449-3
   PubMedGoogle Scholar
• Wu L, Chen M, Mao H, et al. Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal Fc receptor in glomerular podocytes. Int J Mol Med. 2017;39(4):851–860. doi:10.3892/ijmm.2017.2902
   PubMed Web of Science ®Google Scholar
• Rozga J, Piątek T, Małkowski P. Human albumin: old, new, and emerging applications. Ann Transplant. 2013;18:205–217. doi:10.12659/AOT.889188
   PubMed Web of Science ®Google Scholar
• Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783–1787. doi:10.1016/j.febslet.2008.04.057
   PubMed Web of Science ®Google Scholar
• Pentón-Rol G, Cervantes-Llanos M, Martínez-Sánchez G, et al. TNF-alpha and IL-10 downregulation and marked oxidative stress in neuromyelitis optica. J Inflamm. 2009;6:18. doi:10.1186/1476-9255-6-18
   Google Scholar
• Kendall H, Abreu E, Cheng A-L. Serum albumin trend is a predictor of mortality in ICU patients with sepsis. Biol Res Nurs. 2019;21(3):237–244. doi:10.1177/1099800419827600
   PubMed Web of Science ®Google Scholar
• Leite HP, Rodrigues da Silva AV, de Oliveira Iglesias SB, Koch Nogueira PC. Serum albumin is an independent predictor of clinical outcomes in critically ill children. Pediatr Crit Care Med. 2016;17(2):e50–e57. doi:10.1097/PCC.0000000000000596
   PubMed Web of Science ®Google Scholar
• Vincent J-L, Dubois M-J, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237(3):319–334. doi:10.1097/01.SLA.0000055547.93484.87
   PubMed Web of Science ®Google Scholar
• Shi L, Li D, Zhang Y, et al. Factors influencing the degree of disability in patients with neuromyelitis optica spectrum disorders. Eur J Med Res. 2023;28(1):426. doi:10.1186/s40001-023-01404-z
   PubMed Web of Science ®Google Scholar